- Home
- SCD vs TKNO Comparison
SCD vs TKNO Comparison
Compare SCD & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCD
- TKNO
- Stock Information
- Founded
- SCD 2003
- TKNO 1996
- Country
- SCD United States
- TKNO United States
- Employees
- SCD N/A
- TKNO N/A
- Industry
- SCD Trusts Except Educational Religious and Charitable
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- SCD Finance
- TKNO Health Care
- Exchange
- SCD Nasdaq
- TKNO Nasdaq
- Market Cap
- SCD 259.3M
- TKNO 244.7M
- IPO Year
- SCD N/A
- TKNO 2021
- Fundamental
- Price
- SCD $17.82
- TKNO $5.06
- Analyst Decision
- SCD
- TKNO Buy
- Analyst Count
- SCD 0
- TKNO 2
- Target Price
- SCD N/A
- TKNO $5.00
- AVG Volume (30 Days)
- SCD 62.6K
- TKNO 125.4K
- Earning Date
- SCD 01-01-0001
- TKNO 11-07-2024
- Dividend Yield
- SCD 9.63%
- TKNO N/A
- EPS Growth
- SCD N/A
- TKNO N/A
- EPS
- SCD N/A
- TKNO N/A
- Revenue
- SCD N/A
- TKNO $34,940,000.00
- Revenue This Year
- SCD N/A
- TKNO $3.22
- Revenue Next Year
- SCD N/A
- TKNO $14.88
- P/E Ratio
- SCD N/A
- TKNO N/A
- Revenue Growth
- SCD N/A
- TKNO N/A
- 52 Week Low
- SCD $11.33
- TKNO $1.16
- 52 Week High
- SCD $15.87
- TKNO $5.46
- Technical
- Relative Strength Index (RSI)
- SCD 67.07
- TKNO 58.56
- Support Level
- SCD $17.36
- TKNO $4.47
- Resistance Level
- SCD $17.96
- TKNO $4.93
- Average True Range (ATR)
- SCD 0.39
- TKNO 0.40
- MACD
- SCD 0.03
- TKNO -0.02
- Stochastic Oscillator
- SCD 88.14
- TKNO 73.39
About SCD LMP Capital and Income Fund Inc.
Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.